Totally implantable venous catheter in 278 oncology patients
DOI:
https://doi.org/10.32635/2176-9745.RBC.2000v46n1.3401Keywords:
Long-Term Venous Access, Cateter, Indwelling, Vascular Access, CancerAbstract
Totally implanted venous catheter provides safe and comfortable long-term vascular access. Implantation and removal of the catheter is associated with low risk of complication. Our objetive is to report the experience ivith 278 ports implanted by a single surgeon in our institution. To be selected for the procedure patients needed: histological proven cancer, estimated survival of more than 3 months and indication of systemic chemoterapy. Surgical and maintenance protocols were previously defined. Between 3190 and 3/98, 278 catheters ivere im planted in 272 patients. The study average follow-up is 382 days (5-2897), with a total of 106.457 days. Mean age ofthe patients was 50,2 years and female patients comprised 64,8% of the population. Access vein were: internaijugular (67,9%), external jugular (26,5%), saphena (2,2%>), cephlic (1,7%) and subclavia (1,7%). The most commom complication was reversible obstruction (0,2611000 days); hematoma (6,11% of the total population and 62% of the in leukemic patients), leaking (0,2/1000 days); thombosis (0,03/1000 days); occurred less frequently. Twenty episodies of infection were reported 0,19/1000 days: lumen (6), peri-porth (7) and sepsis (7). Thirty-four ports were removed, 26 due to complications and 8 at the end ofthe treatment. Currently, 45,2% of the patients are alive with functional catheters. Among all patients, 74,5% had no catheter-related complication. In our experience, catheters represent a safe and efficient adjuvant in cancer patients. Leukemic patients are at high risk for complications, mainly hematomas.
Downloads
References
RICHARD ALEXANER, ALICE B. LUCAS, ELIZABETH P. STEINHAUS, MICFFAELTOROSIAN. Vascular access in the cancer patient. 1th Ed. J. B. Lippincott Company 1994, pg 19
AUBANIAC R: Injection intraveineuse sous-claviculaire. Avantages et technique. Press Med 60: 1456, 1952.
BROVIACJW, COLEJJ, SCHRIBNERBH. A silicone rubber atrial catheter for prolonged parenteral alimentation. Surg Gynecol Obstet 1973; 136: 602-606
HICKMAM RO, BUCKNER CD, CEIFE RA, SANDERS JE, STEWART P, THOMAS ED. A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surg Gynecol Obstet 1979; 148: 871-875
NIEDERHUBERJE, ENSMINGERW, GYVES JW, LIPERMAN M, DOAN K, COZZIE. TotaUy implanted venous and arterial access system to replace externai cath eters in câncer tratment. Surgery 1982; 92: 706-712
BROTHERS TE, VON MOLE LK, NIEDERHUBER JE, ROBERTS JÁ, WALKER-REWS S, ENSMINGER WD. Experience with subcutaneous infusion ports in three hundred patients. Surg Gynecol Obstet 1988; 166: 295-301.
ROSS MN, HAASE GM, POOLE MA, BURLINGTON JD, ODOM LF. Comparison oftotally implanted reservoirs with externai catheters as venous access devices in pediatric oncologic patients. Surg Gynecol Obstet 1988;167:141-144 .
GREENE FL, MOORE W, STRICKL G, MCFARL J. Comparison of a totally implantable access device for chemotherapy (Port-A-Cath) and long-term percutaneous catheterization (Broviac). Couth Med J 1988; 81: 580-603
GREENE FL, MOORE W, STRICKL G, MCFARL J. Comparison of a totally implantable access device for chemotherapy (Port-A-Cath) and long-term percutaneous catheterization (Broviac). Couth Med J 1988; 81: 580-603. DOI: https://doi.org/10.1097/00007611-198805000-00010
THOMPSON WR, ALEXANDER HR, MARTIN AJ, FLETCHER JR, GROSH BC. Percutaneous subclavian catheterization for prolonged systemic chemoterapy. J Surg Oncol 1985; 29: 184-186 DOI: https://doi.org/10.1002/jso.2930290311
MIRRO et al. A comparision of placement techniques and complications of extenalized and implantable port use in children with câncer. J Pediatr Surg 1990; 25: 120- 124 DOI: https://doi.org/10.1016/S0022-3468(05)80176-9
REED WR NEWMAN KA. A improved technique for the insertion of Hickman catheters in patients with thrombocytopenia and granulocitopenia. Surg Ginecol Obstet 1983; 156: 355-358
YAKOUN M, JOYEUX H, SOLASSOL C. catheterization of internal jugular vein for total parenteral nutrition. World] Surg 1982; 6: 369-371 DOI: https://doi.org/10.1007/BF01653561
JANSEN RFM, WIGGERS T, VAN GEEL BN, VAN PUTTEN WLJ. Assesment of insertion techniques and complication rates of dual lumen central venous cath eters in patients with hematological malignances. World L Surg 1988; 12: 509-510
SAGOR G, MITCHENERE P, LAYFIELD J, PRENTICE HG, KIRIK RM. Prolonged acess to the venous system using the Hickman right atrial catheter. Ann R Coll Surg Engl 1983; 65: 47-49
GUENIERC, FERREIRA], PECTORJC. Prolonged venous access in cancer patients. Eur J Surg Oncol 1989: 15: 553-555
CLARKE DE, RAFFINTA, Infectious complications of indwelling long-term central venous catheters. Chest 1990; 97: 966-972 DOI: https://doi.org/10.1378/chest.97.4.966
SEVERIAN C, NELSON J. Frequency of infections associated with implanted Systems vs cuffed, tunneled silastic catheters in patientes with acute leukemia. Am J Dis Child 1991; 145: 1433-1438 DOI: https://doi.org/10.1001/archpedi.1991.02160120101028
INGRAM J, WEITZMAN S, GREENBERG ML, PARKIN P, FILER R. Complications of indwelling venous acess lines in the pediatric hematology patients: a prospective comparision of external venous catheter and subcutaneous port. AM J Pediatr Hematol Oncol 1991; 13: 130-136 DOI: https://doi.org/10.1097/00043426-199122000-00003
MUELLER et al. A prospective randomized trial comparing the infectious and noninfectious complications of na externalized cathter versus a subcutaneously im planted device in cancer patients. J Clin Oncol 1992; 12: 1943-1948 DOI: https://doi.org/10.1200/JCO.1992.10.12.1943
PEGUES et al. Comparison of infections in Hickman and implanted port catheters in adult solid tumor patients. J Surg Oncol 1992; 49: 156-162 DOI: https://doi.org/10.1002/jso.2930490306
KEUNG et al. Comparative study of infectious complications of different types of ebronie central venous access device. Câncer 1994; 73: 2832-2837 DOI: https://doi.org/10.1002/1097-0142(19940601)73:11<2832::AID-CNCR2820731128>3.0.CO;2-V
BRAR KA, MURRAY DL, LEADERI. Central venous catheter infections in pediatric patients in a communitary bospital. Infection 1988; 16: 86-90 DOI: https://doi.org/10.1007/BF01644309
HARTMAN GE SHOCHAT SJ. Management of sptic complications associated witb Silastic catbeters in cbildbood malignancy. Pediatr Infect Dis J 1987;6: 1042-1047 DOI: https://doi.org/10.1097/00006454-198706110-00009
STUART RK; SHIKORA AS; AKERMAN P; et al; Incidence of arrtytmia witb venous catheter insertion end exebange. JPEN 14:152-155, 1990 DOI: https://doi.org/10.1177/0148607190014002152
SHULMAN et al. Use of hypocloric acid to clear obstructec central venous catheters. JPEN 1988; 12: 509-510 DOI: https://doi.org/10.1177/0148607188012005509
PENNINGTON CR, PITHIE AD. Ethanol lock in tbe management of cateter occlusion. JPEN 1987; 11: 507-508 DOI: https://doi.org/10.1177/0148607187011005507
WACHS T. Urokinase administration in pediatric pa tients witb occluded central venous catbeters. JIN 1990; 13: 100-102
LAWSON M, BOTTINO JC, HURTUBISE MR, MCCREDIE BCB. The use of urokinase to restore the pathency of occluded central venous catheters. AMJ Inttraven Tber Clin Nutr 1982; 5: 29-32
MOSS JF, WAGMAN LD, RIIHIMAKIDU, TERZ JJ. Central venous thrombosis related to silastic Hickman-Broviac catheters in na oncologic population. JPEN 1989; 13: 397-400 DOI: https://doi.org/10.1177/0148607189013004397
KRAMER FL, GOODMAN J, ALLEN S. Thrombolytic tberapy in catbeter-related subclavian venous trombosis. J Can Assoe Radiol 1987; 38: 106-108
STILLMAN RM, SOLIMAN R GARCIA L, SAWYER PN. Etiology of catbeter-associated sepsis. Arch Surg 1977; 112: 1497-1499 DOI: https://doi.org/10.1001/archsurg.1977.01370120087011
SWEED M, GUENTER P, LUCENTE K, et al. Long-term central venous catbeters in patients with acquired immunodeficiency syndrome. Am-J-Infect-Contol 1995; 23: 194-9 DOI: https://doi.org/10.1016/0196-6553(95)90041-1
EASTRIDGE BJ. LEFOR AT. Complications of indwelling venous access devices in cancer patients. J Clin-Oncol 1995; 13: 233-8 DOI: https://doi.org/10.1200/JCO.1995.13.1.233
KRUPSKIG, FROSCHLE. GW, WEH FJ, et al. Cen tral venous access devices in treatment of patients with malignant tumors; venous port, central venous catbeter and Hickman catbeter. Cost-experiences with 135 port implantatios and patient attitude. Chirurg 1995; 66: 202-7
BARNES. Wbew sbould tbe “infected” subcutaneous infusion reservoir be removed? Am-Surg. 1996; 62: 203-6
